ZYDUSLIFEBSEZydus Lifesciences LtdHighNegative
Announced Tue, 5 May · 09:46 IST

Receipt of Demand Order-In-Original from Deputy Commissioner of CGST & Central Excise, Ahmedabad North Commissionerate by Zydus VTEC Limited, a wholly owned subsidiary company.

Regulatory & Legal View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.8%1-day move
₹905.00
prior close
₹904.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.0+0.1+0.1+3.8+3.9+3.9+6.1+2.6+9.8+19.0+20.5+26.6
Up moveDown movePending
AI summary

Zydus VTEC Limited, a wholly owned subsidiary of Zydus Lifesciences, has received a demand Order-In-Original from the Deputy Commissioner of CGST & Central Excise, Ahmedabad North Commissionerate. The order pertains to alleged availment of inadmissible Input Tax Credit under the CGST Act, 2017 for the period September 2020 to March 2023. The demand and penalty amounts are Rs. 9.00 million each (totaling Rs. 18 million). The order was received on May 4, 2026 at 11:21 a.m. The company states it has strong merits and intends to appeal against the order. Management has confirmed there is no material financial impact on either ZVTEC or the parent company, and is hopeful of a favorable outcome based on past High Court and Supreme Court judgments.

Likely market impact

The financial impact appears negligible at Rs. 18 million relative to the company's scale. However, this represents a regulatory/tax dispute that investors should monitor as the appeal process unfolds. The stock is unlikely to see significant reaction given the company's stated confidence and the relatively small amount involved.